EGFR and lung adenocarcinoma: In this study, we proposed a deep learning model using CT images to predict EGFR mutation status among patients with lung adenocarcinoma manifesting as pGGN and demonstrated its clinical utility using an independent cohort made up of patients who received EGFR-TKI (83 GGNs of 64 patients) and treatment response as the reference standard.